The FDA accepted an NDA for a bictegravir and lenacapavir single-tablet regimen for adults with HIV-1 who have achieved virologic suppression.

The US Food and Drug Administration is moving to speed drug development and review by launching real-time clinical trials.

Florida’s KidCare expansion has been mired in lawsuits and ongoing negotiations between the state and federal regulators.

For children treated for suspected septic shock, outcomes were similar in fluid resuscitation with balanced crystalloid fluid vs 0.9% saline.

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

Physical activity-based interventions may help reduce chronic postsurgical pain, but current evidence is inconclusive.